Literature DB >> 10644864

Morphologic abnormalities in the brain of chronically hemodialyzed patients without cerebrovascular disease.

T Kamata1, A Hishida, T Takita, K Sawada, N Ikegaya, Y Maruyama, H Miyajima, E Kaneko.   

Abstract

In this study, the authors evaluated the cerebral atrophy in 56 chronic hemodialyzed patients, who did not have clinical episodes or radiologic findings of cerebrovascular diseases, and 42 controls. Using computed tomography (CT) images, brain atrophy index (BAI), the proportion of subarachnoidal plus ventricular space in the cranial cavity, and ventricular area index (VAI), percent area of ventricle in the brain, were calculated. CT of the brain demonstrated an age-dependent increase in BAI in both hemodialyzed patients and controls. BAI and VAI were greater in hemodialyzed patients than healthy controls and the difference was significant at ages under 60 years in BAI and at ages less than 50 years in VAI. The atrophy of the frontal parts of the brain in patients on hemodialysis for 10 years or more was significantly greater than in patients dialyzed for less than 10 years. There was a significant negative correlation between BAI or VAI and hematocrit. These findings indicate that renal failure or hemodialysis itself might cause cerebral atrophy, and that the cerebral atrophy is more prominent in patients on hemodialysis for a long duration and with low hematocrit. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2000        PMID: 10644864     DOI: 10.1159/000013551

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  19 in total

1.  Near-infrared spectroscopy underestimates cerebral oxygenation in hemodialysis patients.

Authors:  Shino Matsukawa; Shinichi Kai; Toshiyuki Mizota
Journal:  J Anesth       Date:  2019-05-06       Impact factor: 2.078

2.  Altered brain functional connectivity in hemodialysis patients with end-stage renal disease: a resting-state functional MR imaging study.

Authors:  Gang Zheng; Jiqiu Wen; Liping Zhang; Jianhui Zhong; Xue Liang; Wenwei Ke; Xiang Kong; Tiezhu Zhao; Yong He; Xinian Zuo; Song Luo; Long Jiang Zhang; Guang Ming Lu
Journal:  Metab Brain Dis       Date:  2014-05-21       Impact factor: 3.584

3.  Increased presence of cognitive impairment in hemodialysis patients in the absence of neurological events.

Authors:  James B Post; Kel G Morin; Mary Sano; Adejoke B Jegede; Erik Langhoff; Ann M Spungen
Journal:  Am J Nephrol       Date:  2011-12-29       Impact factor: 3.754

4.  Cerebral blood flow regulation in end-stage kidney disease.

Authors:  Justin D Sprick; Joe R Nocera; Ihab Hajjar; W Charles O'Neill; James Bailey; Jeanie Park
Journal:  Am J Physiol Renal Physiol       Date:  2020-09-28

5.  The impact of hemodialysis on cognitive dysfunction in patients with end-stage renal disease: a resting-state functional MRI study.

Authors:  Hui Juan Chen; Rongfeng Qi; Xiang Kong; Jiqiu Wen; Xue Liang; Zhe Zhang; Xue Li; Guang Ming Lu; Long Jiang Zhang
Journal:  Metab Brain Dis       Date:  2015-07-07       Impact factor: 3.584

Review 6.  Adult chronic kidney disease: neurocognition in chronic renal failure.

Authors:  Nikhil S Koushik; Steven F McArthur; Anne D Baird
Journal:  Neuropsychol Rev       Date:  2009-08-25       Impact factor: 7.444

Review 7.  Hypertension in patients with chronic kidney disease.

Authors:  Ranjan Chanda; Andrew Z Fenves
Journal:  Curr Hypertens Rep       Date:  2009-10       Impact factor: 5.369

8.  Predominant gray matter volume loss in patients with end-stage renal disease: a voxel-based morphometry study.

Authors:  Long Jiang Zhang; Jiqiu Wen; Ling Ni; Jianhui Zhong; Xue Liang; Gang Zheng; Guang Ming Lu
Journal:  Metab Brain Dis       Date:  2013-09-26       Impact factor: 3.584

9.  Rationale and design of a multi-centre randomised controlled trial of individualised cooled dialysate to prevent left ventricular systolic dysfunction in haemodialysis patients.

Authors:  Aghogho Odudu; Mohamed Tarek Eldehni; Apostolos Fakis; Christopher William McIntyre
Journal:  BMC Nephrol       Date:  2012-06-21       Impact factor: 2.388

10.  Is intracranial atherosclerosis an independent risk factor for cerebral atrophy? A retrospective evaluation.

Authors:  S Erbay; R Han; M Aftab; Kelly H Zou; J F Polak; Rafeeque A Bhadelia
Journal:  BMC Neurol       Date:  2008-12-22       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.